BMO cuts Salesforce stock price target on growth concerns By Investing.com

BMO Capital cut its price target on Salesforce to $215 from $225 while keeping an Outperform rating, citing limited changes to fiscal 2027 top-line growth expectations. Salesforce’s Q1 fiscal 2027 revenue grew 12% year over year in constant currency, above the 10.5% midpoint expectation, but analysts remain split on the durability of growth and valuation. Recent calls ranged from Piper Sandler and Stifel at positive ratings to DA Davidson and BMO trimming targets, reflecting a cautious but not bearish outlook.

Analysis

The setup is less about the headline numbers and more about dispersion inside software: CRM is still trapped in a multiple-compression regime where incremental beats are being treated as maintenance, not inflection. That means the stock can outperform on cash flow optics yet still lag if investors don’t believe near-term revenue acceleration is self-sustaining. In practice, the market is paying for proof of a second derivative improvement, not just stability.

INFA is the cleaner second-order beneficiary because any evidence that CRM’s growth is improving through acquisition/expansion rather than broad-based core demand tends to re-rate the asset as a strategic input, not just a standalone data platform. That creates a subtle read-through for adjacent infrastructure names: if enterprise software buyers are still spending selectively on data integration while freezing broader app budgets, the winners are the picks-and-shovels vendors with high attach rates and cross-sell leverage. This is a narrow but durable demand pattern, and it argues for relative-value positioning over outright beta.

The bearish catalyst for CRM is time, not magnitude: if the next one to two quarters fail to show sustained net-new growth improvement, the market will likely continue to fade every rally as a capital-return story rather than a growth story. Conversely, a clean upward revision to fiscal 2027 growth assumptions would force shorts to cover because the valuation already embeds modest improvement. The asymmetry is that downside is slower but persistent, while upside requires a narrative change.

The contrarian view is that the consensus may be underestimating how much buybacks can support the stock even without visible reacceleration, especially if free cash flow remains resilient. But that support only matters if software multiples stop contracting. If multiples stabilize, CRM can grind higher; if they don’t, capital returns will merely slow the drawdown, not reverse it.

Key Decisions for Investors

• Keep CRM as a relative-short versus higher-quality enterprise software baskets for the next 4-8 weeks; the risk/reward favors fading rallies until the market sees proof of sustained reacceleration.
• Go long INFA against CRM on a 1-3 month horizon; if CRM’s growth improvement is being driven by ecosystem strength, INFA should retain a scarcity premium and outperform on strategic value alone.
• Sell near-dated CRM upside calls into strength; the setup is range-bound unless management can force estimate revisions higher, and call premium should decay faster than the stock can re-rate.
• If CRM pulls back to a low-multiple support zone, consider a tactical long only via call spread, not stock, to express the buyback/cash-flow floor with capped downside.
• Avoid chasing broad software beta until the next two reporting cycles clarify whether this is a genuine demand inflection or just a cash-flow story; the cleaner trade is relative value, not directional exposure.